Pharm-Rx Tetracaine Hydrochloride

Pharm-Rx Tetracaine Hydrochloride operates in over-the-counter (OTC) capacities within pharmaceuticals and nutraceuticals. Composed of tetracaine hydrochloride, it falls under active pharmaceutical ingredients (APIs) within pharmaceutical actives and precursors. Pharm-Rx Tetracaine Hydrochloride is commonly used in various pharmaceutical formulations for its anesthetic properties.

Chemical Name: Tetracaine Hydrochloride

CAS Number: 136-47-0

Chemical Inventories: AICS (Australia), DSL (Canada), EINECS (EU), NZIoC (New Zealand), TCSI (Taiwan)

Certifications & Compliance: California Proposition 65, FDA 29 CFR 1910.1200

Ask Pharm-Rx Chemical Corp. Questions

Mark Bostel avatar

    Enhanced TDS

    Identification & Functionality

    Chemical Name
    Pharma & Nutraceuticals Functions
    Molecular formula
    C₁₅H₂₄N₂O₂· HCl
    Technologies
    Product Families
    Definition

    Tetracaine Hydrochloride contains not less than 98.0% and not more than 102.0% of tetracaine hydrochloride (C₁₅H₂₄N₂O₂ · HCl), calculated on the anhydrous basis.

    Chemical Structure

    Pharm-Rx Aluminum Hydroxide Gel - Chemical Structure - 1

    Applications & Uses

    Properties

    Physical Form
    Soluble In
    Typical Properties
    ValueUnitsTest Method / Conditions
    Molecular Weight300.82--

    Regulatory & Compliance

    Certifications & Compliance
    Chemical Inventories
    FDA Disclaimer

    These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    USP Reference Standards
    • USP Aminobenzoic Acid RS USP Tetracaine Hydrochloride RS USP Tetracaine Related Compound B RS 4-(Butylamino)benzoic acid
    • C11H15NO2 193.24 USP Tetracaine Related Compound C RS Methyl 4-(butylamino)benzoate
    • C12H17NO2 207.35

    Packaging & Availability

    Labelling Information

    Where it is intended for use in preparing injectable dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable or other sterile dosage forms.